Gwen Fewell's Contact Details

Gwen Fewell's Company Details

SynVivo

Huntsville, AL, US • 5 - 9 Employees
Major Drugs

SynVivo's proprietary microfluidic technology links the high-tech domains of microfluidics and bioengineering for broad applications in the life science arena. SynVivo microfluidic chips mimic the microvascular environment for culturing cells that retain many of the features found in human tissues and organs. SynVivo has commercialized 3D Tissue and Organ-on-Chip models that accelerate real-time studies of cellular behavior, drug delivery, and drug discovery by providing a biologically realistic microenvironment that more accurately depicts in vivo reality. These models recreate complex in vivo microvasculature including scale, morphology, hemodynamic shear stress, and cellular interactions in an in vitro microfluidic chip environment and enable real-time visualization and quantitation due to their side-by-side architecture. SynVivo's microfluidic platform has the potential to be a game-changer for diseases like cancer because it enables the use of cells from patient biopsies to replicate the tumor environment for testing the efficacy of drugs or drug combinations—thus providing a novel personalized medicine approach to cancer therapy.